McKesson, Cardinal and AmerisourceBergen scrutinized over opioid arm-twisting

16th October 2017 Uncategorised 0

Investors are demanding change at the top of the Big Three drug distributors after a bombshell investigation exposed a lack of opioid controls—and a successful push on Capitol Hill to hobble the DEA.

More: McKesson, Cardinal and AmerisourceBergen scrutinized over opioid arm-twisting
Source: fierce